banner
 
bar

program

slides
bar
 
 

Optimizing Patient Outcomes in
Type 2 Diabetes

WebCAST

pre-program survey
We Invite You to Take a Moment and Complete This
Pre-Program Knowledge and Clinical Performance Survey.
Thank You

Webcast CME Disclosure

Please read this notice and click the acknowledgement
at the bottom of the page to continue.

Program Medium

Internet-based program

Estimated Time to Complete Educational Activity

2.75 hours

Course Overview

In this web-based program, physicians will learn how recent advances in basic and clinical research have helped to advance the understanding of treatment advances in Type 2 Diabetes

Release Date

June11, 2013

Expiration Date

June 11, 2015

Method of Physician Participation Utilized in Learning Process

There are no fees for participating and receiving CME credit for this activity. During the period June 11, 2013 through June 11 2015, participants must 1) read the learning objectives and faculty disclosures; 2) study the educational activity, and are expected to view all 10 segments totaling 2.75 hours to successfully complete the activity and earn CME credit; 3) register and complete the evaluation form and post-test; 4) score 100% on the post-test; and 5) print out your CME certificate.

Registration

Participation in this WebCAST is complimentary, and clinicians are invited to view this CME-certified program and/or share this invitation with other colleagues, departmental staff members, and healthcare professionals.

Grantor Support

sanofi-diabetes Supported by an educational grant
from sanofi-aventis U.S. Inc., A SANOFI COMPANY

Accreditation Statement

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the University of Massachusetts Medical School and CMEducation Resources, LLC. The University of Massachusetts Medical School is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement

The University of Massachusetts Medical School designates this enduring material for a maximum of 2.75 AMA PRA Category 1 Credits(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Policy on Faculty & Provider Disclosure

It is the policy of the University of Massachusetts Medical School to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the University of Massachusetts Medical School are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships with those supporting the activity or others whose products or services are discussed. Faculty disclosure will be provided in the activity materials.

Program Faculty and Disclosure

HAROLD LEBOVITZ, MD, FACE
Program Chairman

Professor of Medicine
State University of NY Health Science Center at Brooklyn
Brooklyn, NY

Consultant: AstraZeneca, Bristol Myers Squibb, Sanofi, Amylin
Stock Shareholder: Merck, Abbott



CHARLES F. SHAEFER Jr, MD, FACP
Assistant Clinical Professor of Medicine
Medical College of Georgia
Senior Partner
University Physicians
Augusta, GA

Consultant: Sanofi-Aventis, BMS-AZ
Speaker's Bureau: Sanofi-Aventis, Amylin, BI/Lilly, BMS-AZ, Novartis


GEORGE E. DAILEY, MD
Clinical Professor of Medicine
University of California San Diego
Senior Consultant in Endocrinology
Scripps Clinic
La Jolla, CA

Consultant: sanofi-Aventis, BMS, Astra-Zeneca
Speaker’s Bureau: sanofi-aventis
Grant/Research Support: Sanofi-Aventis, Novo Nordisk, Biodel, Halozyme, GSK



MELANIE E. MABREY, DNP, RN, ACNP-BC, BC- ADM
Clinical Associate
Duke University Schools of Medicine and Nursing
Associate Medical Director
Duke Regional Hospital
Raleigh, NC

Consultant and Speaker’s Bureau: Sanofi Pharmaceuticals

Program Managers and Web Editor Disclosure

Program Manager Gideon Bosker, MD has nothing to disclose.

Program Reviewer Denise Leary has nothing to disclose.

Educational Objectives

Upon completion of this activity, participants will be able to:

  • Understand the epidemiology, scope of the problem, and burden of Type 2 diabetes, with a special focus on the risks, complications, and costs of suboptimal glycemic control;
  • Be able to explain the rationale and evidence for achieving individualized therapeutic goals in T2D, and for optimizing glycemic control with combination insulin-based regimens in the primary care setting:
  • Be better able to deploy multimodal therapy, including insulin as a foundation agent, to optimize clinical outcomes in patients with type 2 diabetes;
  • Be able to apply guidelines, strategies, drug selection strategies, and recommendations endorsed by Year 2012 ADA/EASD Position Statement on glycemic management of T2D, to the front lines of primary care practice;
  • Become more proficient at deploying insulin-based treatment early in the course of diabetes, identify insulin intensification strategies that are appropriate for an individual patient, and combine insulin with other oral and or injectable agents (including IBTs) as part of multimodal treatment for T2D;

Hardware and Software Requirements:

To participate in this program, viewers must have a PC or Macintosh computer that has active, ongoing internet access for the duration of the program, as well as a compatible Flash-viewer. An email address is required for registration, and a printer is required to print out the CME certificate..

Privacy Policy

When you participate in a CME activity offered by CMEducation Resources, we ask you for your name, degree, affiliation, street address, telephone number, fax number, and/or e-mail address (the "Information"). We use that Information in the following ways:

  • We use the Information to grade your post-test and to send you a certificate of completion of the CME activity. If we use a third-party company to grade your post-test and issue certificates of completion, we will give the Information to that company for that purpose only.
  • For each CME activity that you take, you must complete an evaluation questionnaire. That questionnaire asks if you are willing to participate in a follow-up survey. If you answer yes, we will use your name and contact information to send you the survey.
  • We may use the Information to send you information about other CME activities that CMEducation Resources is offering.
  • If our company is acquired by or merged into another company, we may make the Information available to the new owner/entity to use in the ways described above, to enable it to continue our business.
  • You should check this privacy policy periodically to see whether we have made any changes.

Disclaimer

Copyright © 2013 by CMEducation Resources, LLC All rights reserved.

Reproduction, distribution, or translation without express written permission is strictly prohibited.

Content on this webcast reflects the opinions, output, and analyses of experts, investigators, educators, and clinicians whose activities for, while independent, are commercially supported by the sponsor noted at the start of each activity.

Content on this webcast is not meant to be, nor substitute for national guidelines or recommendations generated by professional, academic societies, colleges, or associations.

Content on this webcast is intended for educational value only. Its contents, analyses, and any recommendation made herein are intended to make scientific information and opinion available to health professionals, to stimulate thought, and further investigation. This webcast is not designed nor is any aspect of the contents here intended to provide advice regarding medical diagnosis or treatment for any individual case. Any decisions regarding diagnosis and/or management of any individual patient or group of patients should be made on individual basis after having consulted appropriate sources, whether they be appropriate consultants and/or guidelines and recommendations issued by national organizations, professional societies, governmental health organizations, or similar bodies. This webcast is not intended for use by the layman.

Opinions expressed herein are not necessarily those of CMEducation Resources, LLC, program supporters or accreditors, but reflect the opinions and analyses of the experts who have authored the material. Mention of products or services does not constitute endorsement. Clinical, legal, financial, and other comments are offered for general guidance only; and professional counsel should be sought for all specific situations.

bar

program

slides
bar

I have read this CME information statement and wish to participate in this CME activity.

Copyright © CMEducation Resources, LLC

 
6

 

Key Program Topics Include:

b-Cell
A1c
AACE
AACE/ACE
ACCORD
ADA
ADA/EASD
ADVANCE
Basal Insulin
biguanides
DCCT
Diabetes

DPP-4 inhibitor
Dyslipidemia
ESRD
Exenatide
FPG
Glargine
glimiperide
GLP agonist
Glucose
glyburide
Glycemia
Glycemic
HbA1c

HDL
Hypertension
Hypoglycemia
incretin
Insulin
Insulin detemir
insulinopenia
LDL
metformin
Microalbumin
NHANES
NPH
Obesity

Type 2
PPG
prandial
PREMIX
Sulfonylureas
T2D
T2DM
Thiazolidinedione
troglitazone
TZD
UKPDS
VADT